Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity
ACT-OCD
The Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity: A Randomized Controlled Trial
2 other identifiers
interventional
36
1 country
1
Brief Summary
This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedJune 3, 2026
May 1, 2026
8 months
May 26, 2026
May 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Obsessive-Compulsive Symptom Severity
Change in OCD symptom severity measured by Yale-Brown Obsessive Compulsive Scale (Y-BOCS) from baseline to post-treatment.
Baseline and 10-12 weeks (post-treatment)
OCD Symtom Severity- DOCS
Change in OCD symptom severity measured by Dimensional Obsessive-Compulsive Scale (DOCS) from baseline to post treatment.
Baseline and 10-12 weeks
Study Arms (2)
ACT-Based Group Psychotherapy
EXPERIMENTALEmotion-focused Acceptance and Commitment Therapy (ACT) based structured group psychotherapy targeting emotional awareness, acceptance, cognitive defusion, present-moment focus, values clarification and committed action. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Supportive Group Psychotherapy
ACTIVE COMPARATORUnstructured supportive group psychotherapy aimed at providing emotional support, enhancing coping with stress and maintaining current functioning. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Interventions
Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria
- Age between 18-65 years
- Minimum literacy level
- Willingness to participate and providing informed consent
You may not qualify if:
- Age over 65 years
- Diagnosis of alcohol or substance use disorder
- Comorbid psychotic disorder or intellectual disability
- Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months
- Comorbid psychiatric disorder that would impair group therapy compliance
- History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Istanbul, Istanbul, 34722, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet Emrah Karadere
Goztepe Prof Dr Suleyman Yalcın City Hospital
- PRINCIPAL INVESTIGATOR
Kaasım Fatih Yavuz
Baglamsal Bilimler ve Psikoterapiler Dernegi
- STUDY DIRECTOR
Beyza Baran Boz
Goztepe Prof Dr Suleyman Yalcın City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label study. Due to the nature of psychotherapy interventions, blinding of participants and therapists is not possible. Outcome assessors are not blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry
Study Record Dates
First Submitted
May 26, 2026
First Posted
June 3, 2026
Study Start
October 1, 2025
Primary Completion
June 1, 2026
Study Completion
June 1, 2026
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share